JG
XENT

Jefferies Group’s Intersect ENT, Inc XENT Stock Holding History

Jefferies Group’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,000
Closed -$322K – 2987
2019
Q1 		$322K Hold
10,000
– – ﹤0.01% 1772
2018
Q4 		$282K Sell
10,000
-28,100
-74% -$823K ﹤0.01% 1678
2018
Q3 		$1.09M Buy
+38,100
New +$1.14M 0.01% 1278

Other funds holding XENT

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Jefferies Group's XENT Position: Q3 2019 in Review

Jefferies Group sold out of Intersect ENT, Inc (XENT) in Q3 2019, closing a stake of 27,124 shares — an estimated $617K sold.

Jefferies Group first reported a position in XENT in Q3 2018 and held it in 4 quarters. The position peaked at $617K in Q2 2019. 112 funds tracked by Wall St. Rank hold XENT as of Q3 2019.

  • Jefferies Group reported no remaining Intersect ENT, Inc position as of Q3 2019 after selling out during the quarter.
  • Jefferies Group sold 27,124 Intersect ENT, Inc shares in Q3 2019, an estimated $617K.
  • Jefferies Group first reported a position in Intersect ENT, Inc in Q3 2018 and held it in 4 quarters.
  • Jefferies Group's Intersect ENT, Inc position peaked at $617K in Q2 2019.
  • 112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2019.

Based on Jefferies Group's 13F filing for Q3 2019, filed 13 Nov 2019.